Shijiazhuang Yiling Pharmaceutical (002603.SZ): The clinical trial registration application for the Traditional Chinese Medicine new drug "Lianhua Yuping Granules" has been approved.

Shijiazhuang Yiling Pharmaceutical (002603.SZ) announced that its wholly-owned subsidiary Peking Yiling Pharmaceutical Co., Ltd. ("Peking...

Zhitong FinanceDec 13 04:21 ET

Yiling Pharmaceutical Unit Gets Nod to Market Simvastatin Tablets in US

MT NewswiresDec 2 04:00 ET

Shenzhen Stock Exchange: Adjustment of the sample stocks for the Shenzhen component index, Chinext price index, and szse 100 price index.

On December 2, the Shenzhen Stock Exchange announced that according to the index compilation rules, the Shenzhen Stock Exchange and Shenzhen Securities Information Co., Ltd. decided to implement periodic adjustments to the Shenzhen Component Index, chinext price index, szse 100 price index, and other indexes on December 16, 2024.

Zhitong FinanceDec 1 20:13 ET

Shijiazhuang Yiling Pharmaceutical (002603.SZ): Simvastatin tablets obtain the approval number from the FDA in the usa.

Shijiazhuang Yiling Pharmaceutical (002603.SZ) issued an announcement. Recently, the company received a notification from the US Food and Drug Administration (FDA)...

Zhitong FinanceNov 29 06:09 ET

Shijiazhuang Yiling Pharmaceutical's Tongluo Mingmu Capsules Added to National Medical Insurance Catalog

MT NewswiresNov 29 02:02 ET

Shijiazhuang Yiling Pharmaceutical (002603.SZ): Exclusive product Tongluo Mingmu Capsules included in the national medical insurance catalog through negotiations.

gelonhui November 28th, Shijiazhuang Yiling Pharmaceutical (002603.SZ) announced that according to the notice issued by the National Medical Insurance Administration's website on November 28, 2024, titled 'Notice on Issuing <National Basic Medical Insurance, Work-Related Injury Insurance, and Maternity Insurance Pharmaceutical Catalog (2024)>' (Medical Insurance Issue [2024] No. 33), Shijiazhuang Yiling Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company")'s exclusive product Tongluo Mingmu Capsules have passed the medical insurance negotiation and have been included in the 'National Basic Medical Insurance, Work-Related Injury Insurance, and Maternity Insurance Pharmaceutical Catalog (2024)' for the first time. In addition to this new entry into medical insurance negotiation this time.

Gelonghui FinanceNov 28 05:17 ET